NetraMark Holdings (TSE:AIAI) has released an update.
NetraMark Holdings Inc. has expanded its product offerings with a suite designed to improve clinical trial outcomes and enhance market access strategies. The new products include advanced machine learning tools for protocol enrichment, covariate analysis, and target product profile enhancement, aiming to optimize clinical trials and drug development processes.
For further insights into TSE:AIAI stock, check out TipRanks’ Stock Analysis page.
